Cti Biopharm Corp
(CTIC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -101,687 | -62,619 | -82,836 | -95,395 | -180,029 |
| Depreciation Amortization | 2,346 | 2,411 | 1,842 | 1,771 | 5,228 |
| Accounts receivable | N/A | 0 | N/A | 991 | -895 |
| Accounts payable and accrued liabilities | 3,123 | -310 | -1,403 | -1,484 | 2,786 |
| Other Working Capital | 2,916 | -3,855 | -5,034 | -6,909 | 78,219 |
| Other Operating Activity | 30,526 | 3,915 | 24,303 | 12,840 | 14,484 |
| Operating Cash Flow | $-62,776 | $-60,458 | $-63,128 | $-88,186 | $-80,207 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -350 | 600 | 1,903 |
| PPE Investments | -2,937 | -2,672 | -1,926 | -591 | -1,907 |
| Net Acquisitions | -17,764 | N/A | N/A | 6,844 | 6,212 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -1,800 |
| Sale Of Investment | N/A | N/A | N/A | 14,987 | N/A |
| Investing Cash Flow | $-20,701 | $-2,672 | $-2,276 | $21,840 | $4,408 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | N/A | N/A | 185,209 |
| Debt Repayment | N/A | -21,163 | -38,515 | -9,965 | -10,724 |
| Common Stock Issued | N/A | N/A | N/A | 67,253 | 5,080 |
| Dividend Paid | N/A | N/A | N/A | -3,111 | -18,857 |
| Other Financing Activity | 87,216 | 108,167 | 88,237 | 40,598 | -86,982 |
| Financing Cash Flow | $87,216 | $87,004 | $49,722 | $94,775 | $73,726 |
| Exchange Rate Effect | -355 | 529 | 520 | -690 | -3,653 |
| Beginning Cash Position | 47,052 | 22,649 | 37,811 | 10,072 | 15,798 |
| End Cash Position | 50,436 | 47,052 | 22,649 | 37,811 | 10,072 |
| Net Cash Flow | $3,384 | $24,403 | $-15,162 | $27,739 | $-5,726 |
| Free Cash Flow | |||||
| Operating Cash Flow | -62,776 | -60,458 | -63,128 | -88,186 | -80,207 |
| Capital Expenditure | -2,937 | -2,703 | -2,011 | -1,478 | -1,907 |
| Free Cash Flow | -65,713 | -63,161 | -65,139 | -89,664 | -82,114 |